nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.684	1	CbGaD
Trifluoperazine—HTR2A—arteriole—type 1 diabetes mellitus	0.00633	0.0683	CbGeAlD
Trifluoperazine—CALY—islet of Langerhans—type 1 diabetes mellitus	0.00491	0.0529	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—type 1 diabetes mellitus	0.00445	0.0481	CbGeAlD
Trifluoperazine—S100A4—islet of Langerhans—type 1 diabetes mellitus	0.00423	0.0457	CbGeAlD
Trifluoperazine—S100A4—nephron tubule—type 1 diabetes mellitus	0.00341	0.0368	CbGeAlD
Trifluoperazine—CALM2—peripheral nervous system—type 1 diabetes mellitus	0.00323	0.0348	CbGeAlD
Trifluoperazine—CALM1—peripheral nervous system—type 1 diabetes mellitus	0.00321	0.0347	CbGeAlD
Trifluoperazine—S100A4—cardiovascular system—type 1 diabetes mellitus	0.00306	0.033	CbGeAlD
Trifluoperazine—S100A4—kidney—type 1 diabetes mellitus	0.003	0.0323	CbGeAlD
Trifluoperazine—S100A4—pancreas—type 1 diabetes mellitus	0.00298	0.0321	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00271	0.0293	CbGeAlD
Trifluoperazine—UGT1A4—kidney—type 1 diabetes mellitus	0.00263	0.0284	CbGeAlD
Trifluoperazine—TNNC1—cardiovascular system—type 1 diabetes mellitus	0.00258	0.0278	CbGeAlD
Trifluoperazine—S100A4—lymphoid tissue—type 1 diabetes mellitus	0.00257	0.0278	CbGeAlD
Trifluoperazine—CALM2—nerve—type 1 diabetes mellitus	0.00252	0.0272	CbGeAlD
Trifluoperazine—CALM1—nerve—type 1 diabetes mellitus	0.0025	0.027	CbGeAlD
Trifluoperazine—DRD2—nerve—type 1 diabetes mellitus	0.00231	0.025	CbGeAlD
Trifluoperazine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00196	0.0211	CbGeAlD
Trifluoperazine—XDH—kidney—type 1 diabetes mellitus	0.00192	0.0207	CbGeAlD
Trifluoperazine—CALM3—islet of Langerhans—type 1 diabetes mellitus	0.00155	0.0167	CbGeAlD
Trifluoperazine—HTR2A—nerve—type 1 diabetes mellitus	0.00153	0.0165	CbGeAlD
Trifluoperazine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00148	0.0498	CcSEcCtD
Trifluoperazine—SIGMAR1—islet of Langerhans—type 1 diabetes mellitus	0.00139	0.015	CbGeAlD
Trifluoperazine—CALM3—retina—type 1 diabetes mellitus	0.00133	0.0143	CbGeAlD
Trifluoperazine—CALM3—nephron tubule—type 1 diabetes mellitus	0.00125	0.0135	CbGeAlD
Trifluoperazine—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00124	0.0419	CcSEcCtD
Trifluoperazine—CALM2—islet of Langerhans—type 1 diabetes mellitus	0.00122	0.0132	CbGeAlD
Trifluoperazine—CALM1—islet of Langerhans—type 1 diabetes mellitus	0.00121	0.0131	CbGeAlD
Trifluoperazine—SIGMAR1—nephron tubule—type 1 diabetes mellitus	0.00112	0.0121	CbGeAlD
Trifluoperazine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00111	0.0375	CcSEcCtD
Trifluoperazine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.00111	0.0119	CbGeAlD
Trifluoperazine—CALM3—pancreas—type 1 diabetes mellitus	0.00109	0.0118	CbGeAlD
Trifluoperazine—CALM2—retina—type 1 diabetes mellitus	0.00104	0.0112	CbGeAlD
Trifluoperazine—CALM1—retina—type 1 diabetes mellitus	0.00104	0.0112	CbGeAlD
Trifluoperazine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00103	0.0346	CcSEcCtD
Trifluoperazine—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.000999	0.0337	CcSEcCtD
Trifluoperazine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00099	0.0334	CcSEcCtD
Trifluoperazine—CALM2—nephron tubule—type 1 diabetes mellitus	0.000981	0.0106	CbGeAlD
Trifluoperazine—CALM1—nephron tubule—type 1 diabetes mellitus	0.000977	0.0105	CbGeAlD
Trifluoperazine—SIGMAR1—pancreas—type 1 diabetes mellitus	0.000975	0.0105	CbGeAlD
Trifluoperazine—DRD2—retina—type 1 diabetes mellitus	0.000958	0.0103	CbGeAlD
Trifluoperazine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000956	0.0322	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.000932	0.0314	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000924	0.0312	CcSEcCtD
Trifluoperazine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000897	0.00968	CbGeAlD
Trifluoperazine—CALM2—cardiovascular system—type 1 diabetes mellitus	0.000882	0.00951	CbGeAlD
Trifluoperazine—CALM1—cardiovascular system—type 1 diabetes mellitus	0.000877	0.00947	CbGeAlD
Trifluoperazine—CALM2—kidney—type 1 diabetes mellitus	0.000862	0.00931	CbGeAlD
Trifluoperazine—CALM1—kidney—type 1 diabetes mellitus	0.000859	0.00926	CbGeAlD
Trifluoperazine—CALM2—pancreas—type 1 diabetes mellitus	0.000857	0.00925	CbGeAlD
Trifluoperazine—CALM1—pancreas—type 1 diabetes mellitus	0.000853	0.0092	CbGeAlD
Trifluoperazine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000827	0.00892	CbGeAlD
Trifluoperazine—Asthma—Ramipril—type 1 diabetes mellitus	0.00078	0.0263	CcSEcCtD
Trifluoperazine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00078	0.0263	CcSEcCtD
Trifluoperazine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000772	0.026	CcSEcCtD
Trifluoperazine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.000767	0.0259	CcSEcCtD
Trifluoperazine—CALM2—lymphoid tissue—type 1 diabetes mellitus	0.000741	0.00799	CbGeAlD
Trifluoperazine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00074	0.025	CcSEcCtD
Trifluoperazine—CALM1—lymphoid tissue—type 1 diabetes mellitus	0.000737	0.00796	CbGeAlD
Trifluoperazine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000718	0.0242	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000712	0.024	CcSEcCtD
Trifluoperazine—Weight increased—Ramipril—type 1 diabetes mellitus	0.000709	0.0239	CcSEcCtD
Trifluoperazine—Cyamemazine—CHRM2—type 1 diabetes mellitus	0.000697	0.101	CrCbGaD
Trifluoperazine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000695	0.0075	CbGeAlD
Trifluoperazine—Jaundice—Ramipril—type 1 diabetes mellitus	0.000678	0.0228	CcSEcCtD
Trifluoperazine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000649	0.0219	CcSEcCtD
Trifluoperazine—HTR2A—retina—type 1 diabetes mellitus	0.000632	0.00682	CbGeAlD
Trifluoperazine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000615	0.0207	CcSEcCtD
Trifluoperazine—Mequitazine—CHRM2—type 1 diabetes mellitus	0.000605	0.088	CrCbGaD
Trifluoperazine—Ethopropazine—CHRM2—type 1 diabetes mellitus	0.000591	0.0859	CrCbGaD
Trifluoperazine—Erythema—Ramipril—type 1 diabetes mellitus	0.000543	0.0183	CcSEcCtD
Trifluoperazine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000535	0.00577	CbGeAlD
Trifluoperazine—Nervousness—Ramipril—type 1 diabetes mellitus	0.000528	0.0178	CcSEcCtD
Trifluoperazine—HTR2A—kidney—type 1 diabetes mellitus	0.000523	0.00564	CbGeAlD
Trifluoperazine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000522	0.0176	CcSEcCtD
Trifluoperazine—Tremor—Ramipril—type 1 diabetes mellitus	0.000509	0.0172	CcSEcCtD
Trifluoperazine—Agitation—Ramipril—type 1 diabetes mellitus	0.000499	0.0168	CcSEcCtD
Trifluoperazine—Angioedema—Ramipril—type 1 diabetes mellitus	0.000496	0.0167	CcSEcCtD
Trifluoperazine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000486	0.0164	CcSEcCtD
Trifluoperazine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000484	0.00523	CbGeAlD
Trifluoperazine—Triflupromazine—CHRM2—type 1 diabetes mellitus	0.000484	0.0704	CrCbGaD
Trifluoperazine—Cough—Ramipril—type 1 diabetes mellitus	0.000474	0.016	CcSEcCtD
Trifluoperazine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000471	0.0159	CcSEcCtD
Trifluoperazine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000452	0.0152	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000443	0.0149	CcSEcCtD
Trifluoperazine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000431	0.0145	CcSEcCtD
Trifluoperazine—Mesoridazine—CHRM2—type 1 diabetes mellitus	0.000425	0.0618	CrCbGaD
Trifluoperazine—Anorexia—Ramipril—type 1 diabetes mellitus	0.000423	0.0142	CcSEcCtD
Trifluoperazine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000414	0.014	CcSEcCtD
Trifluoperazine—ABCB1—retina—type 1 diabetes mellitus	0.000414	0.00447	CbGeAlD
Trifluoperazine—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.000411	0.0598	CrCbGaD
Trifluoperazine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000401	0.0135	CcSEcCtD
Trifluoperazine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000395	0.0133	CcSEcCtD
Trifluoperazine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000394	0.0133	CcSEcCtD
Trifluoperazine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00039	0.00421	CbGeAlD
Trifluoperazine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000385	0.013	CcSEcCtD
Trifluoperazine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000382	0.0129	CcSEcCtD
Trifluoperazine—Constipation—Ramipril—type 1 diabetes mellitus	0.000379	0.0128	CcSEcCtD
Trifluoperazine—Propiomazine—CHRM2—type 1 diabetes mellitus	0.000358	0.0521	CrCbGaD
Trifluoperazine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000352	0.0119	CcSEcCtD
Trifluoperazine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00035	0.0118	CcSEcCtD
Trifluoperazine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00035	0.00378	CbGeAlD
Trifluoperazine—ABCB1—kidney—type 1 diabetes mellitus	0.000343	0.0037	CbGeAlD
Trifluoperazine—ABCB1—pancreas—type 1 diabetes mellitus	0.00034	0.00367	CbGeAlD
Trifluoperazine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000327	0.011	CcSEcCtD
Trifluoperazine—Thioridazine—CHRM2—type 1 diabetes mellitus	0.000321	0.0466	CrCbGaD
Trifluoperazine—Asthenia—Ramipril—type 1 diabetes mellitus	0.000318	0.0107	CcSEcCtD
Trifluoperazine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000314	0.0106	CcSEcCtD
Trifluoperazine—Methotrimeprazine—CHRM2—type 1 diabetes mellitus	0.000306	0.0445	CrCbGaD
Trifluoperazine—Promethazine—CHRM2—type 1 diabetes mellitus	0.000302	0.0438	CrCbGaD
Trifluoperazine—Loxapine—CHRM2—type 1 diabetes mellitus	0.000296	0.043	CrCbGaD
Trifluoperazine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000294	0.00318	CbGeAlD
Trifluoperazine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000293	0.00988	CcSEcCtD
Trifluoperazine—Quetiapine—CHRM2—type 1 diabetes mellitus	0.000289	0.042	CrCbGaD
Trifluoperazine—Rash—Ramipril—type 1 diabetes mellitus	0.00028	0.00942	CcSEcCtD
Trifluoperazine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000279	0.00941	CcSEcCtD
Trifluoperazine—Headache—Ramipril—type 1 diabetes mellitus	0.000278	0.00936	CcSEcCtD
Trifluoperazine—Promazine—CHRM2—type 1 diabetes mellitus	0.000265	0.0386	CrCbGaD
Trifluoperazine—Nausea—Ramipril—type 1 diabetes mellitus	0.000263	0.00888	CcSEcCtD
Trifluoperazine—Loxapine—ADRB1—type 1 diabetes mellitus	0.000252	0.0366	CrCbGaD
Trifluoperazine—Clozapine—CHRM2—type 1 diabetes mellitus	0.000248	0.0361	CrCbGaD
Trifluoperazine—Chlorpromazine—CHRM2—type 1 diabetes mellitus	0.000233	0.0339	CrCbGaD
Trifluoperazine—Acepromazine—ALB—type 1 diabetes mellitus	0.000153	0.0223	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—type 1 diabetes mellitus	0.00015	0.0218	CrCbGaD
Trifluoperazine—Thiothixene—ALB—type 1 diabetes mellitus	0.000147	0.0214	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—type 1 diabetes mellitus	0.000147	0.0214	CrCbGaD
Trifluoperazine—Clomipramine—ALB—type 1 diabetes mellitus	0.000117	0.0169	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—type 1 diabetes mellitus	7.99e-05	0.0116	CrCbGaD
Trifluoperazine—CALM2—Immune System—CD80—type 1 diabetes mellitus	1.02e-05	5.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD80—type 1 diabetes mellitus	1.02e-05	5.45e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.01e-05	5.42e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.01e-05	5.42e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.01e-05	5.41e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS2—type 1 diabetes mellitus	1e-05	5.36e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.99e-06	5.34e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.98e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.96e-06	5.32e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.96e-06	5.32e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.93e-06	5.31e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.92e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.83e-06	5.25e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.81e-06	5.24e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.8e-06	5.23e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.77e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.76e-06	5.21e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.74e-06	5.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.74e-06	5.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD80—type 1 diabetes mellitus	9.73e-06	5.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EGFR—type 1 diabetes mellitus	9.72e-06	5.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS2—type 1 diabetes mellitus	9.7e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS2—type 1 diabetes mellitus	9.7e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.7e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.66e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.63e-06	5.14e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.59e-06	5.12e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.58e-06	5.12e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.56e-06	5.1e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.5e-06	5.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	9.45e-06	5.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.42e-06	5.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.42e-06	5.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD80—type 1 diabetes mellitus	9.41e-06	5.03e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD80—type 1 diabetes mellitus	9.41e-06	5.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EGFR—type 1 diabetes mellitus	9.4e-06	5.02e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EGFR—type 1 diabetes mellitus	9.4e-06	5.02e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.38e-06	5.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.38e-06	5.01e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CD86—type 1 diabetes mellitus	9.34e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—EGFR—type 1 diabetes mellitus	9.33e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—INS—type 1 diabetes mellitus	9.19e-06	4.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CD86—type 1 diabetes mellitus	9.03e-06	4.83e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CD86—type 1 diabetes mellitus	9.03e-06	4.83e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.03e-06	4.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	9.03e-06	4.82e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—EGFR—type 1 diabetes mellitus	9.03e-06	4.82e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	9.02e-06	4.82e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	8.98e-06	4.8e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.97e-06	4.79e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	8.93e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—TYK2—type 1 diabetes mellitus	8.9e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—INS—type 1 diabetes mellitus	8.89e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—INS—type 1 diabetes mellitus	8.89e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.86e-06	4.73e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	8.79e-06	4.7e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.68e-06	4.64e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.64e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.64e-06	4.61e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—TYK2—type 1 diabetes mellitus	8.61e-06	4.6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—TYK2—type 1 diabetes mellitus	8.61e-06	4.6e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.6e-06	4.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.57e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.57e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.42e-06	4.5e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	8.34e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNG—type 1 diabetes mellitus	8.33e-06	4.45e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	8.29e-06	4.43e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.28e-06	4.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TYK2—type 1 diabetes mellitus	8.21e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.21e-06	4.38e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.19e-06	4.37e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.16e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.15e-06	4.35e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.15e-06	4.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.1e-06	4.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS3—type 1 diabetes mellitus	8.06e-06	4.31e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	8.06e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNG—type 1 diabetes mellitus	8.06e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNG—type 1 diabetes mellitus	8.06e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD4—type 1 diabetes mellitus	8.05e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.04e-06	4.29e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.02e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.01e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.01e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.98e-06	4.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TYK2—type 1 diabetes mellitus	7.95e-06	4.24e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TYK2—type 1 diabetes mellitus	7.95e-06	4.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.9e-06	4.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.9e-06	4.22e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	7.88e-06	4.21e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.87e-06	4.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.84e-06	4.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.84e-06	4.19e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.83e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS3—type 1 diabetes mellitus	7.8e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS3—type 1 diabetes mellitus	7.8e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD4—type 1 diabetes mellitus	7.78e-06	4.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD4—type 1 diabetes mellitus	7.78e-06	4.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	7.76e-06	4.14e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	7.74e-06	4.13e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—INS—type 1 diabetes mellitus	7.7e-06	4.11e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.62e-06	4.07e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	7.61e-06	4.07e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.59e-06	4.06e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.59e-06	4.05e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.59e-06	4.05e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.5e-06	4.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.49e-06	4e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—type 1 diabetes mellitus	7.47e-06	3.99e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.46e-06	3.99e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.45e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—INS—type 1 diabetes mellitus	7.45e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—INS—type 1 diabetes mellitus	7.45e-06	3.98e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL1B—type 1 diabetes mellitus	7.43e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD4—type 1 diabetes mellitus	7.43e-06	3.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL2—type 1 diabetes mellitus	7.4e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.37e-06	3.93e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.35e-06	3.92e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.33e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.31e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—type 1 diabetes mellitus	7.23e-06	3.86e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—type 1 diabetes mellitus	7.23e-06	3.86e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL1B—type 1 diabetes mellitus	7.19e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL1B—type 1 diabetes mellitus	7.19e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD4—type 1 diabetes mellitus	7.19e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD4—type 1 diabetes mellitus	7.19e-06	3.84e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL2—type 1 diabetes mellitus	7.16e-06	3.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL2—type 1 diabetes mellitus	7.16e-06	3.82e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—type 1 diabetes mellitus	7.06e-06	3.77e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.04e-06	3.76e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	7.02e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.93e-06	3.7e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.91e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.91e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.9e-06	3.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—type 1 diabetes mellitus	6.83e-06	3.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—type 1 diabetes mellitus	6.83e-06	3.65e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CD80—type 1 diabetes mellitus	6.81e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.8e-06	3.63e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.8e-06	3.63e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.79e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.78e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—type 1 diabetes mellitus	6.75e-06	3.61e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.68e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.68e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.67e-06	3.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.66e-06	3.56e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.65e-06	3.55e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.64e-06	3.55e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.64e-06	3.55e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.61e-06	3.53e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.59e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.59e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—type 1 diabetes mellitus	6.53e-06	3.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—type 1 diabetes mellitus	6.53e-06	3.49e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—type 1 diabetes mellitus	6.44e-06	3.44e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—STAT3—type 1 diabetes mellitus	6.23e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—type 1 diabetes mellitus	6.23e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—type 1 diabetes mellitus	6.23e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.23e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.2e-06	3.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—STAT3—type 1 diabetes mellitus	6.03e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—STAT3—type 1 diabetes mellitus	6.03e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.02e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.02e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.99e-06	3.2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.99e-06	3.2e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.87e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.86e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.83e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.83e-06	3.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.77e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.77e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.76e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.75e-06	3.07e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.75e-06	3.07e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—type 1 diabetes mellitus	5.75e-06	3.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.74e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.72e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.67e-06	3.03e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—type 1 diabetes mellitus	5.66e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.66e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.65e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.65e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.65e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.63e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.62e-06	3e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.62e-06	3e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.59e-06	2.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.56e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.56e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—type 1 diabetes mellitus	5.56e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—type 1 diabetes mellitus	5.56e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—type 1 diabetes mellitus	5.48e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—type 1 diabetes mellitus	5.48e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.46e-06	2.92e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.46e-06	2.92e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	5.35e-06	2.86e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	5.3e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—type 1 diabetes mellitus	5.23e-06	2.79e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.12e-06	2.73e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.1e-06	2.73e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.08e-06	2.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—type 1 diabetes mellitus	5.06e-06	2.7e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—type 1 diabetes mellitus	5.06e-06	2.7e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.93e-06	2.63e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.85e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.84e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.79e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.79e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.76e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.76e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.75e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	4.66e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.64e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.64e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.63e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.63e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.61e-06	2.46e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.61e-06	2.46e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.48e-06	2.39e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.41e-06	2.36e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.4e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—type 1 diabetes mellitus	4.35e-06	2.32e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.33e-06	2.31e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.32e-06	2.31e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.27e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—type 1 diabetes mellitus	4.21e-06	2.25e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—type 1 diabetes mellitus	4.21e-06	2.25e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.08e-06	2.18e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.03e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—type 1 diabetes mellitus	4.02e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.92e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.9e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.9e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.9e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—type 1 diabetes mellitus	3.89e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—type 1 diabetes mellitus	3.89e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.66e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.54e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.54e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.44e-06	1.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.39e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.38e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.33e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.32e-06	1.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.81e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.72e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.72e-06	1.45e-05	CbGpPWpGaD
